Literature DB >> 16694183

THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.

H Chasis1, N Jolliffe, H W Smith.   

Abstract

Entities:  

Year:  1933        PMID： 16694183      PMCID： PMC435965          DOI： 10.1172/JCI100559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  36 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 2.  Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.

Authors:  Tanya Wilcox; Christophe De Block; Arthur Z Schwartzbard; Jonathan D Newman
Journal:  J Am Coll Cardiol       Date:  2020-04-28       Impact factor: 24.094

3.  THE MEASUREMENT OF GLOMERULAR FILTRATION. CREATININE, SUCROSE AND UREA CLEARANCES IN SUBJECTS WITHOUT RENAL DISEASE.

Authors:  A W Winkler; J Parra
Journal:  J Clin Invest       Date:  1937-11       Impact factor: 14.808

4.  THE EFFECTS ON RENAL ACTIVITY OF THE ORAL ADMINISTRATION OF PHLORIZIN IN MAN.

Authors:  W Goldring; C Welsh
Journal:  J Clin Invest       Date:  1934-09       Impact factor: 14.808

5.  GASTRO-INTESTINAL STUDIES. VII. THE EXCRETION OF XYLOSE IN PERNICIOUS ANEMIA.

Authors:  O M Helmer; P J Fouts
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

6.  The elimination of xylose, creatinine and urea by the perfused mammalian kidney.

Authors:  A Hemingway
Journal:  J Physiol       Date:  1935-07-24       Impact factor: 5.182

7.  Structural selectivity of human SGLT inhibitors.

Authors:  Charles S Hummel; Chuan Lu; Jie Liu; Chiari Ghezzi; Bruce A Hirayama; Donald D F Loo; Vladimir Kepe; Jorge R Barrio; Ernest M Wright
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 8.  Development of SGLT1 and SGLT2 inhibitors.

Authors:  Timo Rieg; Volker Vallon
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 9.  SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns.

Authors:  Joshua A Levine; Susan L Karam; Grazia Aleppo
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

10.  Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule.

Authors:  Chiara Ghezzi; Amy S Yu; Bruce A Hirayama; Vladimir Kepe; Jie Liu; Claudio Scafoglio; David R Powell; Sung-Cheng Huang; Nagichettiar Satyamurthy; Jorge R Barrio; Ernest M Wright
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.